Publication & Citation Trends
Publications
0 total
A phase Ib, open-label study evaluating the safety and efficacy of ipatasertib plus rucaparib in patients with metastatic castration-resistant prostate cancer. OA
Cited by 6
Semantic Scholar
A Robust, Fully Automatic Detection Method and Calculation Technique of Midline Shift in Intracranial Hemorrhage and Its Clinical Application OA
Cited by 18
Semantic Scholar
Mitigating ipatasertib‐induced glucose increase through dose and meal timing modifications OA
Cited by 3
Semantic Scholar
Using Deep Neural Networks for Predicting Age and Sex in Healthy Adult Chest Radiographs OA
Cited by 20
Semantic Scholar
Patient-reported outcomes (PROs) from the phase III IMspire150 trial of atezolizumab (A) + cobimetinib (C) + vemurafenib (V) in patients (pts) with BRAFV600+melanoma.
Cited by 1
Semantic Scholar
Abstract CT012: Evaluation of atezolizumab (A), cobimetinib (C), and vemurafenib (V) in previously untreated patients withBRAFV600mutation-positive advanced melanoma: Primary results from the phase 3 IMspire150 trial
Cited by 7
Semantic Scholar
Atezolizumab in Combination With Carboplatin and Nab-Paclitaxel in Advanced Squamous Non-Small-Cell Lung Cancer (IMpower131): Results From a Randomized Phase III Trial. OA
Cited by 401
Semantic Scholar
Research Topics
Cancer Immunotherapy and Biomarkers
(1)
Cutaneous Melanoma Detection and Management
(1)
Lung Cancer Treatments and Mutations
(1)
CAR-T cell therapy research
(1)
Melanoma and MAPK Pathways
(1)